Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Spatial and Bulk Transcriptomics Reveal Distinct Molecular Signatures in Kaposi Sarcoma with and Without other KSHV-Associated Diseases.
Journal: medRxiv : the preprint server for health sciences
Published: December 18, 2025
Spatial and bulk transcriptomics reveal distinct molecular signatures in Kaposi sarcoma with and without other KSHV-associated diseases.
Journal: Journal of translational medicine
Published: December 08, 2025
Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).
Journal: PloS one
Published: January 29, 2019
Identification of a Novel Invasion-Promoting Region in Insulin Receptor Substrate 2.
Journal: Molecular and cellular biology
Published: November 08, 2017
Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells.
Journal: The Journal of biological chemistry
Published: March 11, 2017
Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone.
Journal: Oncotarget
Published: January 22, 2015
Rapamycin prevents the development and progression of mutant epidermal growth factor receptor lung tumors with the acquired resistance mutation T790M.
Journal: Cell reports
Published: January 27, 2014
Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells.
Journal: Cell death & disease
Published: July 25, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026